Sitemap




Recent Posts:

• History of Vouchers
• RACE for Children Act statutory text
• Nature Supports RACE for Children Act
• Congress Tackles #1 Disease Killer of Children
• Manager’s Amendment to the Advancing Hope Act
• Testimony of Nancy Goodman before the Committee on Homeland Security and Governmental Affairs, February 25, 2016
• Kids v Cancer is #4 of Fast Company’s Top 10 Most Innovative Companies in Not-For-Profit
• Priority Review Voucher Fee
• Reauthorization of the Creating Hope Act
• Thank You Book Volume 2
• Kids v Cancer End of Year Letter 2015
• Kids v Cancer Wins Peter Drucker Award for Nonprofit Innovation
• The President of the United States to Declare September 2015 to be National Childhood Cancer Awareness Month
• WRAL Tech Wire, Gregory Phillips and Erin Medlyn. First-to-Market Crucial for Drug Success, Duke Research Finds, September 2, 2015
• FDA Law Blog, Alexander J. Varond. Priority Review Voucher Updates: Valuation, Eligibility Reauthorization, August 31, 2015
• 21st Century Cures, H.R. 6, Reauthorization of Rare Pediatric Disease Priority Review Voucher Incentive Program, Sec. 2152
• Advancing Hope Act, H.R. 1537
• Washington Post, Letter to the Editor
• Another Creating Hope Act Voucher Sold!
• The Cancer Letter: Laws Need to Catch up to the Science, Nancy Goodman, July 30, 2015
• Regulatory Affairs Professional Society, Michael Mezher: EMA Announces Sweeping Overhaul of Pediatric Class Waivers, July 23, 2015
• BioCentury This Week, Compelling Case, Interview by Steve Usdin featuring Dr. Rick Pazdur, April 15, 2015
• U.S. House Reauthorizes Creating Hope Act, July 11, 2015
• USA Today, Lisa Gillespie: Hope for children’s rare drug approval process, June 7, 2015
• Good news for Creating Hope Act, May 21, 2015
• Voucher sells for 245M!
• Kids v Cancer Announces “The Advancing Hope Act” To Reauthorize The Pediatric Priority Review Voucher Program, April 21, 2015
• A St. Patrick’s Day Third Creating Hope Act Voucher! March 14, 2015
• Third Priority Review Voucher
• BioCentury Extra: FDA vouches for United Therapeutics’ Unituxin, March 10, 2015
• Kids v Cancer Congratulates United Therapeutics on Receiving Priority Review Voucher Through the Creating Hope Act, March 10, 2015
• Second Priority Review Voucher
• PriceWaterhouseCoopers Health Research Institute: Consumers taking charge: Kids v Cancer, January 2015 (Page 13)
• Bloomberg Business, Caroline Chen: The CEO Who Saved a Life and Lost His Job, January 22, 2015
• Kids v Cancer End of Year Letter 2014
• Nancy Goodman at the Rare Disease Congressional Caucus, September 17, 2014
• Overview of Articles Published on the Sale of the First Creating Hope Act Voucher
• Overview of Articles Posted on the First Pediatric Priority Review Voucher Sale
• The President of the United States to Declare September 2014 to be National Childhood Cancer Awareness Month
• CNBC Op/Ed, Nancy Goodman: Kids with Cancer Need Access to Drug Trials, November 21, 2014
• CNBC, Meg Tirrell: Fighting Kids’ Cancer, One Voucher at a Time, November 21, 2014
• CNBC: Fighting Kid’s Cancer…Fixing a Broken System, November 21, 2014
• Draft FDA guidance on PRVs
• Ben Shapiro at Action Day Training, June 23, 2014
• BioCentury This Week, Steve Usdin: Targeting PREA, September 29, 2014
• BioCentury This Week: A Voice on Capitol Hill, September 28, 2014
• BioCentury This Week, Steve Usdin: Patching Compassionate Access, September 29, 2014
• Kids v Cancer Newsletter – Voucher Sold For $67.5M!, September 12, 2014
• Kids v Cancer Press Release: Do Kids with Cancer Deserve Drugs? Now that Childhood Rare Disease Drugs are Profitable, They Might Get Them, September 8, 2014
• Nature Reviews: BioMarin Nabs First Paediatric Priority Review Voucher, April 1, 2014
• FDA Law Blog, Kurt Karst: BioMarin Snags the First Rare Pediatric Disease Priority Review Voucher with VIMIZIM Approval, February 17, 2014
• Fox and Friends: Is pediatric cancer research being left behind? Featuring Nancy Goodman, August 6, 2014
• Nancy Goodman at Invitation of Congressman Shimkus and Congressman Davis Comments on the 21st Century Cures Initiative of the House Energy and Commerce Committee in Springfield, IL, September 5, 2014
• PBS: Drugs of Last Resort, August 1, 2014
• BusinessWeek, Josh Eidelson: Sanofi and Regeneron Pay $67.5 Million to Fast-Track a Cholesterol Drug, August 4, 2014
• The Wall Street Journal, Ron Winslow and Joseph Walker: Drug Firms Buy $67.5 Million Voucher to Speed FDA Review, July 30, 2014
• The Pink Sheet, Sue Sutter: Vimizim Voucher A Result Of BioMarin’s Late Request, FDA Flexibility, August 11, 2014
• The Pink Sheet, Sue Sutter: How Much Is A Priority Review Voucher Worth? $67.5 Million Sanofi/Regeneron Say, August 11, 2014
• BioCentury This Week, Steve Usdin: State’s Rights (State Right to Try Laws) , June 30, 2014
• Massachusetts General Hospital Cancer Center, Nancy Goodman Honored, May 23, 2014
• Gabriella Miller Kids First Research Act Signing, April 3, 2014
• BioCentury This Week, Steve Usdin: ASCO’s honest broker, April 21, 2014
• The President of the United States to Declare September 2013 to be National Childhood Cancer Awareness Month
• BioCentury This Week, Compassionate Access, Interview by Steve Usdin featuring Nancy Goodman, April 14, 2013
• BioCentury, Steve Usdin: Regulation, Viral Crossroads, March 31, 2014
• Life Sciences Connect, Meg Egan Auderset: Tropical Disease Priority Review Voucher Accompanies FDA Approval of Impavido for Leishmaniasis, March 25, 2014
• The Lancet, David Ridley: Introduction of European priority review vouchers to encourage development of new medicines for neglected diseases, September 11, 2010
• Developing Countries, David Ridley, Henry Grabowski, Jeffrey Moe: Developing Drugs For Developing Countries, March 2006
• SF Business Times, Ron Leuty: Giving and getting: Mom turns son’s death into new rare-disease drug voucher program, February 24, 2014
• Comments by Nancy Goodman to NCI Director of Consumer Liaison Group, February 19, 2014
• Comments by Nancy Goodman to Journee Mondial contre Le Cancer chez L’Enfant, February 15, 2014
• FDA Press Release: FDA approves Vimizim to treat rare congenital enzyme disorder – First Rare Pediatric Disease Priority Review Voucher, February 14, 2014
• Kids v Cancer Newsletter – The First Creating Hope Act Voucher!
• First Priority Review Voucher
• New York BIO CEO Forum: Presentation by Nancy Goodman, February 9, 2014
• Readers Digest: Everyday Heroes: The Fight of Their Lives, February 5, 2014
• Readers Digest: Kimberly Hiss, Meet the Parents Fighting to End Pediatric Cancer, February 5, 2014
• Kids v Cancer End of Year Letter 2013
• Kids v Cancer Newsletter – Help Change The Landscape Of Pediatric Cancer, December 17, 2013
• Paris BDA Workshop: Improving Oncology Drug Development For Children And Adolescents, Nancy Goodman, November 18 & 19, 2013
• Photos of Nancy Goodman at the Congressional Pediatric Cancer Caucus, September 19, 2013
• Keynote Address by Nancy Goodman to the Alexandria Summit Oncology, delivered with FDA Commissioner Margaret Hamburg, June 26, 2013
• Childhood Cancer Summit: Nancy Goodman of Kids v Cancer with a Creating Hope Act Update, September 19, 2013
• Ben Froman Speaking at “Roll for the Gold”, April 1, 2013
• FiercePharma: J&J Fast-tracked TB Drug OK’d by FDA on Last Day of the Year, December 31, 2012
• Kids v Cancer Newsletter – Happy New Year from Kids v Cancer, December 28, 2012
• Kids v Cancer Newsletter – Kids v Cancer wishes you Happy Holidays, December 21, 2012
• BioCentury This Week: Mothers and Advocates, October 28, 2012
• PLOS Neglected Tropical Diseases: Analysis of Neglected Tropical Disease Drug and Vaccine Development Pipelines to Predict Issuance of FDA Priority Review Vouchers over the Next Decade, October 25, 2012
• Houston Chronicle: Michael McCaul, Brianna Commerford ‘Create Hope’ for Pediatric Cancer Patients, September 21, 2012
• Congressional Childhood Cancer Caucus: Caucus Hosts Third Annual Childhood Cancer Summit, Sep 20, 2012
• The President of the United States to Declare September 2012 to be National Childhood Cancer Awareness Month
• Kids v Cancer Newsletter – President Declares September 2012 National Childhood Cancer Awareness Month, September 12, 2012
• FDA Law Blog: Revised Formula Yields a Lower Priority Review Voucher User Fee, September 12, 2012
• Regulatory Focus: FDA Lowers Fee to Use Priority Review Voucher, September 12, 2012
• Kids v Cancer Newsletter – Sarah and the President, September 6, 2012
• Elsevier Business Intelligence: Another Chance to Make Priority Review Vouchers Work, Michael McCaughan, August 23, 2012
• Fox News: Creating Hope Act Tackles Scarcity of Pediatric Drugs, August 17, 2012
• Kids v Cancer Newsletter – Creating Hope, July 31, 2012
• ABC World News: Cancer-Fighting Mom Leads the Charge to Get Companies to Develop Pediatric Drugs, July 28, 2012